Sanginita Chemicals Past Earnings Performance
Past criteria checks 4/6
Sanginita Chemicals's earnings have been declining at an average annual rate of -51.4%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been declining at an average rate of 2.7% per year. Sanginita Chemicals's return on equity is 3.1%, and it has net margins of 0.9%.
Key information
-51.4%
Earnings growth rate
-51.6%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | -2.7% |
| Return on equity | 3.1% |
| Net Margin | 0.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Sanginita Chemicals Limited (NSE:SANGINITA) Shares Fly 26% But Investors Aren't Buying For Growth
May 01
Revenues Working Against Sanginita Chemicals Limited's (NSE:SANGINITA) Share Price Following 26% Dive
Mar 11Sanginita Chemicals Limited (NSE:SANGINITA) Surges 38% Yet Its Low P/S Is No Reason For Excitement
Jan 02These 4 Measures Indicate That Sanginita Chemicals (NSE:SANGINITA) Is Using Debt Reasonably Well
Dec 30Sanginita Chemicals (NSE:SANGINITA) Seems To Use Debt Quite Sensibly
Sep 05Is Sanginita Chemicals (NSE:SANGINITA) Using Too Much Debt?
Dec 13We Think Sanginita Chemicals (NSE:SANGINITA) Is Taking Some Risk With Its Debt
Feb 15Sanginita Chemicals (NSE:SANGINITA) Has A Somewhat Strained Balance Sheet
Jul 22Is Sanginita Chemicals (NSE:SANGINITA) Using Too Much Debt?
Mar 16Sanginita Chemicals Limited's (NSE:SANGINITA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18Does Sanginita Chemicals (NSE:SANGINITA) Have A Healthy Balance Sheet?
Nov 26
Revenue & Expenses BreakdownBeta
How Sanginita Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,323 | 13 | 12 | 0 |
| 30 Sep 23 | 1,367 | 11 | 11 | 0 |
| 30 Jun 23 | 1,334 | 6 | 10 | 0 |
| 31 Mar 23 | 1,486 | 4 | 11 | 0 |
| 31 Dec 22 | 1,535 | 0 | 10 | 0 |
| 30 Sep 22 | 1,720 | -9 | 8 | 0 |
| 30 Jun 22 | 1,918 | -3 | 7 | 0 |
| 31 Mar 22 | 1,981 | 3 | 7 | 0 |
| 31 Dec 21 | 2,127 | 7 | 6 | 0 |
| 30 Sep 21 | 1,977 | 12 | 6 | 0 |
| 30 Jun 21 | 1,953 | 17 | 5 | 0 |
| 31 Mar 21 | 1,648 | 8 | 5 | 0 |
| 31 Dec 20 | 1,486 | 6 | 5 | 0 |
| 30 Sep 20 | 1,567 | 20 | 5 | 0 |
| 30 Jun 20 | 1,462 | 24 | 6 | 0 |
| 31 Mar 20 | 1,598 | 34 | 6 | 0 |
| 31 Dec 19 | 1,648 | 50 | 5 | 0 |
| 30 Sep 19 | 1,589 | 44 | 5 | 0 |
| 30 Jun 19 | 1,748 | 38 | 5 | 0 |
| 31 Mar 19 | 1,876 | 39 | 5 | 0 |
| 31 Mar 18 | 1,945 | 35 | 6 | 0 |
| 31 Mar 17 | 1,473 | 11 | 3 | 0 |
| 31 Mar 16 | 1,441 | 11 | 4 | 0 |
| 31 Mar 15 | 1,286 | 10 | 5 | 0 |
| 31 Mar 14 | 1,190 | 8 | 8 | 0 |
Quality Earnings: SANGINITA has high quality earnings.
Growing Profit Margin: SANGINITA's current net profit margins (0.9%) are higher than last year (0.02%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SANGINITA's earnings have declined by 51.4% per year over the past 5 years.
Accelerating Growth: SANGINITA's earnings growth over the past year (3648.7%) exceeds its 5-year average (-51.4% per year).
Earnings vs Industry: SANGINITA earnings growth over the past year (3648.7%) exceeded the Chemicals industry -4.9%.
Return on Equity
High ROE: SANGINITA's Return on Equity (3.1%) is considered low.